Serum ATX and LPA levels are significantly increased in patients with hepatocellular carcinoma and are related to the degree of differentiation, indicating that ATX may be involved in the development of liver fibrosis and hepatocellular carcinoma, and may serve as an independent risk factor for recurrence after surgical treatment (30). This evidence concerns the gene LPA and hepatocellular carcinoma.